Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,701-2,712 of 10,592
Drug study icon
CompletedNCT01354353

Safety study of safety and Tolerability in schizophrenia

This study is completed in the United States. It is testing safety and Tolerability for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
TerminatedNCT04951609

Seltorexant for depression

This study was terminated in the United States, in the United Kingdom, in Italy, .... It is testing seltorexant for depression.

In United States
DepressionDrugFrom 12 Years to 17 Years
Countries
United States, United Kingdom, Italy, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04533529

Seltorexant for depression

This study is completed in the United States, in Brazil, in Bulgaria, .... It is testing seltorexant for depression.

In United States
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Brazil, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT04532749

Seltorexant for depression

This study was terminated in the United States, in Argentina, in Chile, .... It is testing seltorexant for depression.

In United States
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Argentina, Chile, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04513912

Seltorexant Compared to Quetiapine XR for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing Seltorexant Compared to Quetiapine XR for depression.

In United States
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT07549581

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

This study is completed in the United States. It is testing SEP-380135 for depression.

In United States
Depression, Schizophrenia, ...DrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Schizophrenia, ...
Drug study icon
CompletedNCT00182078

Sertraline to Prevent PTSD

This study is completed in the United States. It focuses on PTSD.

In United States
PTSD, DepressionDrugFrom 6 Years to 20 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
PTSD, Depression
Other study type icon
CompletedNCT04946656

SPG Block for Opioid Withdrawal

This study is completed in the United States. It is testing SPG Block for Addiction.

In United States
AddictionOtherFrom 22 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Addiction
Behavioral study icon
CompletedNCT05956340

Spoken Language in Mania

This study is completed in the United States. It is testing spoken Language for Bipolarity.

In United States
BipolarityBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
Behavioral study icon
CompletedNCT00156637

Strategies to Improve Schizophrenia Treatment

This study is completed in the United States. It focuses on schizophrenia.

In United States
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.